Hologic has received the FDA's blessing for its 3-D Selenia Dimensions digital breast tomosynthesis system. And, as Mass Device notes, the approval comes just in time for the company, which saw Q1 ...
"The system is designed to increase accuracy when screening women for the presence of cancerous tissue, and to enable a more precise characterization of suspicious lesions," says Jay A. Stein, ...
Hologic Inc.’s Selenia Dimensions 3-D digital mammography tomosynthesis system has received a favorable review, unanimously voted, from the U.S. Food and Drug Administration’s Radiological ...
Breast cancer is the second most common cancer among women in the United States. According to the American Cancer Society, about one in eight U.S. women will develop invasive breast cancer over the ...
Hologic has put forward two studies of its artificial intelligence programs for mammography, showing that an AI tool could maintain high breast cancer detection rates while also simplifying ...
Zacks Investment Research on MSN
HOLX's genius AI mammography flags missed breast cancer cases
Hologic, Inc. HOLX recently announced the latest clinical evidence showing the effectiveness of its Genius AI-based mammography screening technology in improving breast cancer detection. In a ...
BOSTON (MarketWatch) -- Shares of Hologic Inc. jumped Tuesday, rallying as the radiology-device maker raised 2006 sales estimates for its Selenia line of mammography products. Hologic shares ended the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback